nodes	percent_of_prediction	percent_of_DWPC	metapath
Meloxicam—osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.457	1	CpDpCtD
Meloxicam—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.0721	0.223	CbGbCtD
Meloxicam—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0416	0.129	CbGbCtD
Meloxicam—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0383	0.118	CbGbCtD
Meloxicam—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0383	0.118	CbGbCtD
Meloxicam—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0294	0.0908	CbGbCtD
Meloxicam—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.029	0.0897	CbGbCtD
Meloxicam—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0198	0.0613	CbGbCtD
Meloxicam—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0189	0.0585	CbGbCtD
Meloxicam—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0169	0.0521	CbGbCtD
Meloxicam—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0099	0.0306	CbGbCtD
Meloxicam—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00935	0.0289	CbGbCtD
Meloxicam—PTGS2—leg—chronic obstructive pulmonary disease	0.00159	0.148	CbGeAlD
Meloxicam—PGD—respiratory system—chronic obstructive pulmonary disease	0.000989	0.0916	CbGeAlD
Meloxicam—PGD—connective tissue—chronic obstructive pulmonary disease	0.000871	0.0806	CbGeAlD
Meloxicam—PGD—bronchus—chronic obstructive pulmonary disease	0.000814	0.0753	CbGeAlD
Meloxicam—PGD—smooth muscle tissue—chronic obstructive pulmonary disease	0.000797	0.0737	CbGeAlD
Meloxicam—PGD—trachea—chronic obstructive pulmonary disease	0.000731	0.0677	CbGeAlD
Meloxicam—ABCC4—bronchus—chronic obstructive pulmonary disease	0.000579	0.0536	CbGeAlD
Meloxicam—PGD—lung—chronic obstructive pulmonary disease	0.000525	0.0486	CbGeAlD
Meloxicam—PTGS1—respiratory system—chronic obstructive pulmonary disease	0.000414	0.0383	CbGeAlD
Meloxicam—PTGS2—respiratory system—chronic obstructive pulmonary disease	0.000396	0.0366	CbGeAlD
Meloxicam—ABCC4—lung—chronic obstructive pulmonary disease	0.000374	0.0346	CbGeAlD
Meloxicam—PTGS1—connective tissue—chronic obstructive pulmonary disease	0.000365	0.0337	CbGeAlD
Meloxicam—PTGS2—connective tissue—chronic obstructive pulmonary disease	0.000349	0.0323	CbGeAlD
Meloxicam—PTGS1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000334	0.0309	CbGeAlD
Meloxicam—PTGS2—bronchus—chronic obstructive pulmonary disease	0.000326	0.0302	CbGeAlD
Meloxicam—PTGS2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000319	0.0295	CbGeAlD
Meloxicam—PTGS1—trachea—chronic obstructive pulmonary disease	0.000306	0.0283	CbGeAlD
Meloxicam—PTGS2—trachea—chronic obstructive pulmonary disease	0.000293	0.0271	CbGeAlD
Meloxicam—PTGS1—lung—chronic obstructive pulmonary disease	0.00022	0.0204	CbGeAlD
Meloxicam—PTGS2—lung—chronic obstructive pulmonary disease	0.00021	0.0195	CbGeAlD
Meloxicam—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.00106	CcSEcCtD
Meloxicam—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000169	0.00106	CcSEcCtD
Meloxicam—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000169	0.00106	CcSEcCtD
Meloxicam—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000169	0.00106	CcSEcCtD
Meloxicam—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000169	0.00106	CcSEcCtD
Meloxicam—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000169	0.00106	CcSEcCtD
Meloxicam—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000168	0.00106	CcSEcCtD
Meloxicam—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000168	0.00106	CcSEcCtD
Meloxicam—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.00105	CcSEcCtD
Meloxicam—Infection—Montelukast—chronic obstructive pulmonary disease	0.000168	0.00105	CcSEcCtD
Meloxicam—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000168	0.00105	CcSEcCtD
Meloxicam—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000168	0.00105	CcSEcCtD
Meloxicam—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000167	0.00105	CcSEcCtD
Meloxicam—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.00104	CcSEcCtD
Meloxicam—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000166	0.00104	CcSEcCtD
Meloxicam—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000165	0.00104	CcSEcCtD
Meloxicam—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000164	0.00103	CcSEcCtD
Meloxicam—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.00102	CcSEcCtD
Meloxicam—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.00102	CcSEcCtD
Meloxicam—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.00101	CcSEcCtD
Meloxicam—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000161	0.00101	CcSEcCtD
Meloxicam—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.00101	CcSEcCtD
Meloxicam—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000161	0.00101	CcSEcCtD
Meloxicam—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00016	0.001	CcSEcCtD
Meloxicam—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.001	CcSEcCtD
Meloxicam—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00016	0.001	CcSEcCtD
Meloxicam—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.001	CcSEcCtD
Meloxicam—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.000996	CcSEcCtD
Meloxicam—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.000991	CcSEcCtD
Meloxicam—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000157	0.000987	CcSEcCtD
Meloxicam—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000157	0.000987	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000157	0.000985	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000157	0.000985	CcSEcCtD
Meloxicam—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000156	0.000978	CcSEcCtD
Meloxicam—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000156	0.000978	CcSEcCtD
Meloxicam—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000155	0.000972	CcSEcCtD
Meloxicam—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000154	0.000968	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000154	0.000965	CcSEcCtD
Meloxicam—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000154	0.000964	CcSEcCtD
Meloxicam—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000154	0.000964	CcSEcCtD
Meloxicam—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.000961	CcSEcCtD
Meloxicam—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000153	0.000961	CcSEcCtD
Meloxicam—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000153	0.000958	CcSEcCtD
Meloxicam—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000152	0.0031	CbGpPWpGaD
Meloxicam—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000954	CcSEcCtD
Meloxicam—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.000954	CcSEcCtD
Meloxicam—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000152	0.000952	CcSEcCtD
Meloxicam—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000152	0.000952	CcSEcCtD
Meloxicam—ABCC4—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000152	0.00308	CbGpPWpGaD
Meloxicam—PTGS2—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	0.000152	0.00308	CbGpPWpGaD
Meloxicam—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000152	0.000951	CcSEcCtD
Meloxicam—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000151	0.000948	CcSEcCtD
Meloxicam—PGD—Metabolism—GC—chronic obstructive pulmonary disease	0.000151	0.00307	CbGpPWpGaD
Meloxicam—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00015	0.000941	CcSEcCtD
Meloxicam—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00015	0.000939	CcSEcCtD
Meloxicam—ABCC4—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.00015	0.00304	CbGpPWpGaD
Meloxicam—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.000937	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000149	0.000933	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000149	0.000933	CcSEcCtD
Meloxicam—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000149	0.000932	CcSEcCtD
Meloxicam—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000149	0.000932	CcSEcCtD
Meloxicam—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000149	0.000932	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.00093	CcSEcCtD
Meloxicam—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000147	0.000924	CcSEcCtD
Meloxicam—Pain—Formoterol—chronic obstructive pulmonary disease	0.000147	0.000924	CcSEcCtD
Meloxicam—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000147	0.000924	CcSEcCtD
Meloxicam—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000147	0.000924	CcSEcCtD
Meloxicam—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.000923	CcSEcCtD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	0.000147	0.00299	CbGpPWpGaD
Meloxicam—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000147	0.000921	CcSEcCtD
Meloxicam—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.000917	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000146	0.000914	CcSEcCtD
Meloxicam—ABCC4—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	0.000146	0.00296	CbGpPWpGaD
Meloxicam—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000146	0.000913	CcSEcCtD
Meloxicam—ABCC4—Platelet degranulation—ALB—chronic obstructive pulmonary disease	0.000145	0.00295	CbGpPWpGaD
Meloxicam—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.00091	CcSEcCtD
Meloxicam—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.000907	CcSEcCtD
Meloxicam—Pain—Montelukast—chronic obstructive pulmonary disease	0.000144	0.000905	CcSEcCtD
Meloxicam—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.000905	CcSEcCtD
Meloxicam—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000144	0.000903	CcSEcCtD
Meloxicam—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.0009	CcSEcCtD
Meloxicam—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000143	0.000899	CcSEcCtD
Meloxicam—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000898	CcSEcCtD
Meloxicam—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000143	0.000896	CcSEcCtD
Meloxicam—PGD—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000143	0.0029	CbGpPWpGaD
Meloxicam—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000143	0.000895	CcSEcCtD
Meloxicam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000143	0.0029	CbGpPWpGaD
Meloxicam—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000142	0.000892	CcSEcCtD
Meloxicam—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000142	0.000891	CcSEcCtD
Meloxicam—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000142	0.000891	CcSEcCtD
Meloxicam—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000142	0.00089	CcSEcCtD
Meloxicam—CYP2C8—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000142	0.00288	CbGpPWpGaD
Meloxicam—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000142	0.000887	CcSEcCtD
Meloxicam—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000887	CcSEcCtD
Meloxicam—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000141	0.000886	CcSEcCtD
Meloxicam—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000141	0.000884	CcSEcCtD
Meloxicam—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000141	0.000884	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.000881	CcSEcCtD
Meloxicam—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00014	0.00285	CbGpPWpGaD
Meloxicam—PGD—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00014	0.00285	CbGpPWpGaD
Meloxicam—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00014	0.00088	CcSEcCtD
Meloxicam—ABCC4—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000139	0.00283	CbGpPWpGaD
Meloxicam—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.000873	CcSEcCtD
Meloxicam—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.000873	CcSEcCtD
Meloxicam—ABCC4—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	0.000139	0.00282	CbGpPWpGaD
Meloxicam—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—chronic obstructive pulmonary disease	0.000139	0.00281	CbGpPWpGaD
Meloxicam—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000138	0.000866	CcSEcCtD
Meloxicam—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000866	CcSEcCtD
Meloxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000137	0.00279	CbGpPWpGaD
Meloxicam—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000137	0.000859	CcSEcCtD
Meloxicam—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000137	0.000859	CcSEcCtD
Meloxicam—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000137	0.00278	CbGpPWpGaD
Meloxicam—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000136	0.000855	CcSEcCtD
Meloxicam—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000136	0.000855	CcSEcCtD
Meloxicam—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000136	0.000855	CcSEcCtD
Meloxicam—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000136	0.000855	CcSEcCtD
Meloxicam—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000852	CcSEcCtD
Meloxicam—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000136	0.000852	CcSEcCtD
Meloxicam—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000135	0.00275	CbGpPWpGaD
Meloxicam—PTGS1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000135	0.00275	CbGpPWpGaD
Meloxicam—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000135	0.000845	CcSEcCtD
Meloxicam—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000135	0.000844	CcSEcCtD
Meloxicam—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000135	0.000844	CcSEcCtD
Meloxicam—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000134	0.000841	CcSEcCtD
Meloxicam—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.000841	CcSEcCtD
Meloxicam—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000134	0.000839	CcSEcCtD
Meloxicam—PTGS1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000134	0.00272	CbGpPWpGaD
Meloxicam—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000134	0.000837	CcSEcCtD
Meloxicam—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000134	0.000837	CcSEcCtD
Meloxicam—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000836	CcSEcCtD
Meloxicam—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.000835	CcSEcCtD
Meloxicam—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000132	0.000828	CcSEcCtD
Meloxicam—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000131	0.000824	CcSEcCtD
Meloxicam—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000131	0.00082	CcSEcCtD
Meloxicam—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000129	0.000811	CcSEcCtD
Meloxicam—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000129	0.000807	CcSEcCtD
Meloxicam—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000129	0.000807	CcSEcCtD
Meloxicam—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000127	0.000796	CcSEcCtD
Meloxicam—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000127	0.000796	CcSEcCtD
Meloxicam—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000127	0.000796	CcSEcCtD
Meloxicam—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000127	0.000794	CcSEcCtD
Meloxicam—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000124	0.00078	CcSEcCtD
Meloxicam—PTGS1—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000124	0.00252	CbGpPWpGaD
Meloxicam—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000124	0.000776	CcSEcCtD
Meloxicam—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.000776	CcSEcCtD
Meloxicam—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000123	0.00249	CbGpPWpGaD
Meloxicam—PTGS2—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.000122	0.00249	CbGpPWpGaD
Meloxicam—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000122	0.000765	CcSEcCtD
Meloxicam—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000122	0.000765	CcSEcCtD
Meloxicam—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000763	CcSEcCtD
Meloxicam—PTGS2—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	0.000121	0.00247	CbGpPWpGaD
Meloxicam—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000121	0.00076	CcSEcCtD
Meloxicam—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000121	0.00246	CbGpPWpGaD
Meloxicam—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.000752	CcSEcCtD
Meloxicam—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00012	0.000749	CcSEcCtD
Meloxicam—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000118	0.00074	CcSEcCtD
Meloxicam—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.00074	CcSEcCtD
Meloxicam—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.000736	CcSEcCtD
Meloxicam—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000733	CcSEcCtD
Meloxicam—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.000732	CcSEcCtD
Meloxicam—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000729	CcSEcCtD
Meloxicam—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000116	0.000724	CcSEcCtD
Meloxicam—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000115	0.00235	CbGpPWpGaD
Meloxicam—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.000722	CcSEcCtD
Meloxicam—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.000717	CcSEcCtD
Meloxicam—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000114	0.000715	CcSEcCtD
Meloxicam—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000114	0.000715	CcSEcCtD
Meloxicam—PTGS1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000112	0.00228	CbGpPWpGaD
Meloxicam—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000112	0.00228	CbGpPWpGaD
Meloxicam—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000112	0.0007	CcSEcCtD
Meloxicam—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.000698	CcSEcCtD
Meloxicam—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000111	0.00226	CbGpPWpGaD
Meloxicam—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00011	0.000687	CcSEcCtD
Meloxicam—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00011	0.000687	CcSEcCtD
Meloxicam—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000109	0.000682	CcSEcCtD
Meloxicam—Rash—Formoterol—chronic obstructive pulmonary disease	0.000109	0.000682	CcSEcCtD
Meloxicam—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000109	0.000681	CcSEcCtD
Meloxicam—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000109	0.000681	CcSEcCtD
Meloxicam—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000681	CcSEcCtD
Meloxicam—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000108	0.000677	CcSEcCtD
Meloxicam—Headache—Formoterol—chronic obstructive pulmonary disease	0.000108	0.000677	CcSEcCtD
Meloxicam—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000677	CcSEcCtD
Meloxicam—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.000676	CcSEcCtD
Meloxicam—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000108	0.000675	CcSEcCtD
Meloxicam—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000107	0.000673	CcSEcCtD
Meloxicam—Rash—Montelukast—chronic obstructive pulmonary disease	0.000106	0.000668	CcSEcCtD
Meloxicam—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000106	0.000667	CcSEcCtD
Meloxicam—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.000666	CcSEcCtD
Meloxicam—Headache—Montelukast—chronic obstructive pulmonary disease	0.000106	0.000663	CcSEcCtD
Meloxicam—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000658	CcSEcCtD
Meloxicam—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.000655	CcSEcCtD
Meloxicam—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000654	CcSEcCtD
Meloxicam—Piroxicam—ALB—chronic obstructive pulmonary disease	0.000104	1	CrCbGaD
Meloxicam—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000104	0.000649	CcSEcCtD
Meloxicam—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.000647	CcSEcCtD
Meloxicam—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.000644	CcSEcCtD
Meloxicam—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000103	0.000644	CcSEcCtD
Meloxicam—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.000643	CcSEcCtD
Meloxicam—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000103	0.000643	CcSEcCtD
Meloxicam—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000102	0.000642	CcSEcCtD
Meloxicam—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000102	0.000642	CcSEcCtD
Meloxicam—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000102	0.000639	CcSEcCtD
Meloxicam—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.00063	CcSEcCtD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—chronic obstructive pulmonary disease	0.000101	0.00204	CbGpPWpGaD
Meloxicam—Nausea—Montelukast—chronic obstructive pulmonary disease	0.0001	0.000629	CcSEcCtD
Meloxicam—ABCC4—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	0.0001	0.00204	CbGpPWpGaD
Meloxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.98e-05	0.00203	CbGpPWpGaD
Meloxicam—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.94e-05	0.00202	CbGpPWpGaD
Meloxicam—Convulsion—Prednisolone—chronic obstructive pulmonary disease	9.91e-05	0.000622	CcSEcCtD
Meloxicam—Hypertension—Prednisolone—chronic obstructive pulmonary disease	9.88e-05	0.000619	CcSEcCtD
Meloxicam—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.84e-05	0.002	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	9.83e-05	0.002	CbGpPWpGaD
Meloxicam—Nausea—Salbutamol—chronic obstructive pulmonary disease	9.67e-05	0.000606	CcSEcCtD
Meloxicam—Discomfort—Prednisolone—chronic obstructive pulmonary disease	9.63e-05	0.000603	CcSEcCtD
Meloxicam—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	9.6e-05	0.000602	CcSEcCtD
Meloxicam—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	9.55e-05	0.000599	CcSEcCtD
Meloxicam—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	9.55e-05	0.00194	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	9.51e-05	0.00193	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	9.51e-05	0.00193	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	9.49e-05	0.00193	CbGpPWpGaD
Meloxicam—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	9.39e-05	0.000588	CcSEcCtD
Meloxicam—PTGS1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	9.38e-05	0.00191	CbGpPWpGaD
Meloxicam—Oedema—Prednisolone—chronic obstructive pulmonary disease	9.34e-05	0.000585	CcSEcCtD
Meloxicam—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	9.34e-05	0.000585	CcSEcCtD
Meloxicam—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	9.26e-05	0.00188	CbGpPWpGaD
Meloxicam—ABCC4—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	9.2e-05	0.00187	CbGpPWpGaD
Meloxicam—Shock—Prednisolone—chronic obstructive pulmonary disease	9.19e-05	0.000576	CcSEcCtD
Meloxicam—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	9.11e-05	0.000571	CcSEcCtD
Meloxicam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	9.05e-05	0.00184	CbGpPWpGaD
Meloxicam—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	9.03e-05	0.000566	CcSEcCtD
Meloxicam—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	8.94e-05	0.00182	CbGpPWpGaD
Meloxicam—Eye disorder—Prednisone—chronic obstructive pulmonary disease	8.93e-05	0.00056	CcSEcCtD
Meloxicam—Flushing—Prednisone—chronic obstructive pulmonary disease	8.87e-05	0.000556	CcSEcCtD
Meloxicam—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	8.76e-05	0.00178	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	8.76e-05	0.00178	CbGpPWpGaD
Meloxicam—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.74e-05	0.00178	CbGpPWpGaD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	8.73e-05	0.00177	CbGpPWpGaD
Meloxicam—Angiopathy—Prednisone—chronic obstructive pulmonary disease	8.67e-05	0.000543	CcSEcCtD
Meloxicam—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.64e-05	0.00176	CbGpPWpGaD
Meloxicam—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	8.63e-05	0.000541	CcSEcCtD
Meloxicam—PTGS1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.62e-05	0.00175	CbGpPWpGaD
Meloxicam—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	8.53e-05	0.000535	CcSEcCtD
Meloxicam—Insomnia—Prednisolone—chronic obstructive pulmonary disease	8.45e-05	0.00053	CcSEcCtD
Meloxicam—Alopecia—Prednisone—chronic obstructive pulmonary disease	8.44e-05	0.000529	CcSEcCtD
Meloxicam—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	8.39e-05	0.000526	CcSEcCtD
Meloxicam—Mental disorder—Prednisone—chronic obstructive pulmonary disease	8.37e-05	0.000525	CcSEcCtD
Meloxicam—Erythema—Prednisone—chronic obstructive pulmonary disease	8.32e-05	0.000521	CcSEcCtD
Meloxicam—Malnutrition—Prednisone—chronic obstructive pulmonary disease	8.32e-05	0.000521	CcSEcCtD
Meloxicam—PGD—Disease—HDAC2—chronic obstructive pulmonary disease	8.28e-05	0.00168	CbGpPWpGaD
Meloxicam—PGD—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.25e-05	0.00168	CbGpPWpGaD
Meloxicam—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	8.21e-05	0.00167	CbGpPWpGaD
Meloxicam—PTGS1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.17e-05	0.00166	CbGpPWpGaD
Meloxicam—PGD—Metabolism—GCLC—chronic obstructive pulmonary disease	8.16e-05	0.00166	CbGpPWpGaD
Meloxicam—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	8.14e-05	0.00165	CbGpPWpGaD
Meloxicam—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.09e-05	0.00164	CbGpPWpGaD
Meloxicam—Pain—Prednisolone—chronic obstructive pulmonary disease	7.99e-05	0.000501	CcSEcCtD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	7.85e-05	0.0016	CbGpPWpGaD
Meloxicam—Vision blurred—Prednisone—chronic obstructive pulmonary disease	7.84e-05	0.000491	CcSEcCtD
Meloxicam—PTGS1—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	7.73e-05	0.00157	CbGpPWpGaD
Meloxicam—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	7.72e-05	0.000484	CcSEcCtD
Meloxicam—PGD—Disease—KL—chronic obstructive pulmonary disease	7.7e-05	0.00156	CbGpPWpGaD
Meloxicam—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	7.7e-05	0.000482	CcSEcCtD
Meloxicam—Anaemia—Prednisone—chronic obstructive pulmonary disease	7.69e-05	0.000482	CcSEcCtD
Meloxicam—PTGS2—Spinal Cord Injury—LEP—chronic obstructive pulmonary disease	7.61e-05	0.00155	CbGpPWpGaD
Meloxicam—Angioedema—Prednisone—chronic obstructive pulmonary disease	7.6e-05	0.000476	CcSEcCtD
Meloxicam—ABCC4—Hemostasis—TGFB2—chronic obstructive pulmonary disease	7.59e-05	0.00154	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	7.55e-05	0.00153	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.55e-05	0.00153	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	7.54e-05	0.00153	CbGpPWpGaD
Meloxicam—Malaise—Prednisone—chronic obstructive pulmonary disease	7.5e-05	0.00047	CcSEcCtD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	7.48e-05	0.00152	CbGpPWpGaD
Meloxicam—Vertigo—Prednisone—chronic obstructive pulmonary disease	7.47e-05	0.000468	CcSEcCtD
Meloxicam—Syncope—Prednisone—chronic obstructive pulmonary disease	7.46e-05	0.000467	CcSEcCtD
Meloxicam—PTGS2—Spinal Cord Injury—TLR4—chronic obstructive pulmonary disease	7.46e-05	0.00151	CbGpPWpGaD
Meloxicam—PGD—Metabolism—CTGF—chronic obstructive pulmonary disease	7.44e-05	0.00151	CbGpPWpGaD
Meloxicam—Urticaria—Prednisolone—chronic obstructive pulmonary disease	7.42e-05	0.000465	CcSEcCtD
Meloxicam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	7.34e-05	0.00149	CbGpPWpGaD
Meloxicam—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	7.31e-05	0.000458	CcSEcCtD
Meloxicam—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.26e-05	0.00148	CbGpPWpGaD
Meloxicam—Convulsion—Prednisone—chronic obstructive pulmonary disease	7.2e-05	0.000452	CcSEcCtD
Meloxicam—Hypertension—Prednisone—chronic obstructive pulmonary disease	7.18e-05	0.00045	CcSEcCtD
Meloxicam—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.16e-05	0.00146	CbGpPWpGaD
Meloxicam—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.11e-05	0.00145	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—NOS2—chronic obstructive pulmonary disease	7.09e-05	0.00144	CbGpPWpGaD
Meloxicam—Myalgia—Prednisone—chronic obstructive pulmonary disease	7.08e-05	0.000444	CcSEcCtD
Meloxicam—Arthralgia—Prednisone—chronic obstructive pulmonary disease	7.08e-05	0.000444	CcSEcCtD
Meloxicam—Anxiety—Prednisone—chronic obstructive pulmonary disease	7.05e-05	0.000442	CcSEcCtD
Meloxicam—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.03e-05	0.00143	CbGpPWpGaD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	7.03e-05	0.000441	CcSEcCtD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—chronic obstructive pulmonary disease	7e-05	0.00142	CbGpPWpGaD
Meloxicam—Discomfort—Prednisone—chronic obstructive pulmonary disease	6.99e-05	0.000438	CcSEcCtD
Meloxicam—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	6.88e-05	0.000431	CcSEcCtD
Meloxicam—PGD—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.86e-05	0.00139	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—HDAC2—chronic obstructive pulmonary disease	6.81e-05	0.00138	CbGpPWpGaD
Meloxicam—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	6.79e-05	0.000425	CcSEcCtD
Meloxicam—Oedema—Prednisone—chronic obstructive pulmonary disease	6.79e-05	0.000425	CcSEcCtD
Meloxicam—Infection—Prednisone—chronic obstructive pulmonary disease	6.74e-05	0.000423	CcSEcCtD
Meloxicam—Shock—Prednisone—chronic obstructive pulmonary disease	6.68e-05	0.000419	CcSEcCtD
Meloxicam—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	6.66e-05	0.000417	CcSEcCtD
Meloxicam—Tachycardia—Prednisone—chronic obstructive pulmonary disease	6.62e-05	0.000415	CcSEcCtD
Meloxicam—Skin disorder—Prednisone—chronic obstructive pulmonary disease	6.59e-05	0.000413	CcSEcCtD
Meloxicam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	6.58e-05	0.00134	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—APIP—chronic obstructive pulmonary disease	6.57e-05	0.00134	CbGpPWpGaD
Meloxicam—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	6.56e-05	0.000411	CcSEcCtD
Meloxicam—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.49e-05	0.00132	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	6.46e-05	0.00131	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	6.45e-05	0.00131	CbGpPWpGaD
Meloxicam—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	6.18e-05	0.000388	CcSEcCtD
Meloxicam—Dizziness—Prednisolone—chronic obstructive pulmonary disease	6.18e-05	0.000387	CcSEcCtD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.14e-05	0.00125	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—PLAUR—chronic obstructive pulmonary disease	6.14e-05	0.00125	CbGpPWpGaD
Meloxicam—Insomnia—Prednisone—chronic obstructive pulmonary disease	6.14e-05	0.000385	CcSEcCtD
Meloxicam—PTGS2—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	6.13e-05	0.00125	CbGpPWpGaD
Meloxicam—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	6.09e-05	0.000382	CcSEcCtD
Meloxicam—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.06e-05	0.00123	CbGpPWpGaD
Meloxicam—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.98e-05	0.00121	CbGpPWpGaD
Meloxicam—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	5.97e-05	0.000374	CcSEcCtD
Meloxicam—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.91e-05	0.0012	CbGpPWpGaD
Meloxicam—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	5.9e-05	0.00037	CcSEcCtD
Meloxicam—Rash—Prednisolone—chronic obstructive pulmonary disease	5.89e-05	0.000369	CcSEcCtD
Meloxicam—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	5.88e-05	0.000369	CcSEcCtD
Meloxicam—Fatigue—Prednisone—chronic obstructive pulmonary disease	5.85e-05	0.000367	CcSEcCtD
Meloxicam—Headache—Prednisolone—chronic obstructive pulmonary disease	5.85e-05	0.000367	CcSEcCtD
Meloxicam—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.83e-05	0.00118	CbGpPWpGaD
Meloxicam—Constipation—Prednisone—chronic obstructive pulmonary disease	5.8e-05	0.000364	CcSEcCtD
Meloxicam—PGD—Disease—ERBB3—chronic obstructive pulmonary disease	5.77e-05	0.00117	CbGpPWpGaD
Meloxicam—PGD—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.72e-05	0.00116	CbGpPWpGaD
Meloxicam—ABCC4—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	5.68e-05	0.00116	CbGpPWpGaD
Meloxicam—PGD—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.64e-05	0.00115	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	5.61e-05	0.00114	CbGpPWpGaD
Meloxicam—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	5.59e-05	0.000351	CcSEcCtD
Meloxicam—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.57e-05	0.00113	CbGpPWpGaD
Meloxicam—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	5.55e-05	0.000348	CcSEcCtD
Meloxicam—Nausea—Prednisolone—chronic obstructive pulmonary disease	5.55e-05	0.000348	CcSEcCtD
Meloxicam—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.49e-05	0.00112	CbGpPWpGaD
Meloxicam—Urticaria—Prednisone—chronic obstructive pulmonary disease	5.39e-05	0.000338	CcSEcCtD
Meloxicam—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	5.36e-05	0.000336	CcSEcCtD
Meloxicam—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	5.36e-05	0.000336	CcSEcCtD
Meloxicam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.33e-05	0.00108	CbGpPWpGaD
Meloxicam—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.28e-05	0.00107	CbGpPWpGaD
Meloxicam—PGD—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.26e-05	0.00107	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—APIP—chronic obstructive pulmonary disease	5.22e-05	0.00106	CbGpPWpGaD
Meloxicam—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.21e-05	0.00106	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	5.06e-05	0.00103	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5e-05	0.00102	CbGpPWpGaD
Meloxicam—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	5e-05	0.000313	CcSEcCtD
Meloxicam—PGD—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.98e-05	0.00101	CbGpPWpGaD
Meloxicam—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.93e-05	0.001	CbGpPWpGaD
Meloxicam—Asthenia—Prednisone—chronic obstructive pulmonary disease	4.87e-05	0.000305	CcSEcCtD
Meloxicam—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.86e-05	0.000988	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	4.85e-05	0.000986	CbGpPWpGaD
Meloxicam—PGD—Disease—NOS2—chronic obstructive pulmonary disease	4.81e-05	0.000978	CbGpPWpGaD
Meloxicam—Pruritus—Prednisone—chronic obstructive pulmonary disease	4.8e-05	0.000301	CcSEcCtD
Meloxicam—ABCC4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.79e-05	0.000974	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.69e-05	0.000953	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.69e-05	0.000952	CbGpPWpGaD
Meloxicam—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.64e-05	0.000291	CcSEcCtD
Meloxicam—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.64e-05	0.000942	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	4.57e-05	0.000929	CbGpPWpGaD
Meloxicam—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.53e-05	0.000921	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	4.53e-05	0.000919	CbGpPWpGaD
Meloxicam—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.49e-05	0.000281	CcSEcCtD
Meloxicam—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.47e-05	0.000908	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	4.45e-05	0.000904	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	4.45e-05	0.000903	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—MMP1—chronic obstructive pulmonary disease	4.39e-05	0.000891	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.35e-05	0.000885	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.32e-05	0.000877	CbGpPWpGaD
Meloxicam—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.31e-05	0.00027	CcSEcCtD
Meloxicam—ABCC4—Hemostasis—PLAU—chronic obstructive pulmonary disease	4.31e-05	0.000875	CbGpPWpGaD
Meloxicam—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.3e-05	0.000873	CbGpPWpGaD
Meloxicam—Rash—Prednisone—chronic obstructive pulmonary disease	4.28e-05	0.000268	CcSEcCtD
Meloxicam—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.28e-05	0.000268	CcSEcCtD
Meloxicam—Headache—Prednisone—chronic obstructive pulmonary disease	4.25e-05	0.000267	CcSEcCtD
Meloxicam—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	4.25e-05	0.000863	CbGpPWpGaD
Meloxicam—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.24e-05	0.000861	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	4.24e-05	0.000861	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	4.08e-05	0.000829	CbGpPWpGaD
Meloxicam—PGD—Disease—SERPINE1—chronic obstructive pulmonary disease	4.05e-05	0.000823	CbGpPWpGaD
Meloxicam—Nausea—Prednisone—chronic obstructive pulmonary disease	4.03e-05	0.000253	CcSEcCtD
Meloxicam—ABCC4—Hemostasis—NOS2—chronic obstructive pulmonary disease	3.96e-05	0.000804	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.94e-05	0.0008	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.9e-05	0.000792	CbGpPWpGaD
Meloxicam—PGD—Disease—NOS3—chronic obstructive pulmonary disease	3.87e-05	0.000786	CbGpPWpGaD
Meloxicam—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.85e-05	0.000781	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	3.77e-05	0.000766	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.72e-05	0.000756	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	3.7e-05	0.000751	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	3.59e-05	0.00073	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	3.52e-05	0.000715	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.46e-05	0.000702	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	3.46e-05	0.000702	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.43e-05	0.000697	CbGpPWpGaD
Meloxicam—PGD—Metabolism—ALB—chronic obstructive pulmonary disease	3.39e-05	0.000688	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GC—chronic obstructive pulmonary disease	3.36e-05	0.000683	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	3.33e-05	0.000677	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—ALB—chronic obstructive pulmonary disease	3.33e-05	0.000676	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.25e-05	0.000661	CbGpPWpGaD
Meloxicam—PGD—Metabolism—NOS3—chronic obstructive pulmonary disease	3.24e-05	0.000658	CbGpPWpGaD
Meloxicam—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.21e-05	0.000652	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—NOS3—chronic obstructive pulmonary disease	3.18e-05	0.000646	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.14e-05	0.000638	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.13e-05	0.000635	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	3.1e-05	0.000631	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.03e-05	0.000615	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.99e-05	0.000607	CbGpPWpGaD
Meloxicam—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.95e-05	0.000599	CbGpPWpGaD
Meloxicam—ABCC4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.88e-05	0.000585	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	2.84e-05	0.000577	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.83e-05	0.000576	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.81e-05	0.000571	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.79e-05	0.000568	CbGpPWpGaD
Meloxicam—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.79e-05	0.000568	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.79e-05	0.000567	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	2.74e-05	0.000556	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.56e-05	0.000521	CbGpPWpGaD
Meloxicam—PGD—Disease—TGFB1—chronic obstructive pulmonary disease	2.56e-05	0.00052	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.54e-05	0.000517	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.51e-05	0.000511	CbGpPWpGaD
Meloxicam—PGD—Disease—EGFR—chronic obstructive pulmonary disease	2.51e-05	0.00051	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.49e-05	0.000506	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.46e-05	0.000501	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.39e-05	0.000487	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.31e-05	0.00047	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—VEGFA—chronic obstructive pulmonary disease	2.29e-05	0.000466	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.29e-05	0.000465	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.29e-05	0.000465	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.28e-05	0.000463	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.27e-05	0.000461	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	2.23e-05	0.000452	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.13e-05	0.000433	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.11e-05	0.000429	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—TGFB1—chronic obstructive pulmonary disease	2.1e-05	0.000427	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.09e-05	0.000424	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.07e-05	0.000421	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.03e-05	0.000412	CbGpPWpGaD
Meloxicam—PGD—Disease—IL6—chronic obstructive pulmonary disease	1.93e-05	0.000392	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.92e-05	0.000391	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HDAC2—chronic obstructive pulmonary disease	1.84e-05	0.000375	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.84e-05	0.000373	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.82e-05	0.000369	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—TP53—chronic obstructive pulmonary disease	1.73e-05	0.000352	CbGpPWpGaD
Meloxicam—PTGS2—Disease—KL—chronic obstructive pulmonary disease	1.71e-05	0.000348	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.69e-05	0.000344	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.66e-05	0.000337	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.65e-05	0.000335	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.6e-05	0.000326	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.58e-05	0.000321	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.53e-05	0.00031	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.51e-05	0.000307	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.49e-05	0.000304	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.48e-05	0.0003	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.47e-05	0.000299	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.47e-05	0.000298	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.4e-05	0.000284	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.38e-05	0.00028	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.37e-05	0.000277	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	1.35e-05	0.000274	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ERBB3—chronic obstructive pulmonary disease	1.28e-05	0.000261	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.27e-05	0.000259	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.26e-05	0.000255	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.24e-05	0.000252	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.22e-05	0.000247	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.2e-05	0.000244	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.17e-05	0.000238	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.12e-05	0.000228	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.11e-05	0.000225	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.1e-05	0.000223	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NOS2—chronic obstructive pulmonary disease	1.07e-05	0.000218	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.04e-05	0.000211	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.02e-05	0.000208	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.01e-05	0.000205	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.52e-06	0.000193	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	9.5e-06	0.000193	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	9.09e-06	0.000185	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.03e-06	0.000183	CbGpPWpGaD
Meloxicam—PTGS2—Disease—SERPINE1—chronic obstructive pulmonary disease	9.02e-06	0.000183	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NOS3—chronic obstructive pulmonary disease	8.61e-06	0.000175	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.43e-06	0.000171	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.32e-06	0.000169	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.02e-06	0.000163	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	7.93e-06	0.000161	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.75e-06	0.000157	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ALB—chronic obstructive pulmonary disease	7.54e-06	0.000153	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.35e-06	0.000149	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	7.24e-06	0.000147	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—NOS3—chronic obstructive pulmonary disease	7.21e-06	0.000147	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.67e-06	0.000135	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	6.14e-06	0.000125	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	5.87e-06	0.000119	CbGpPWpGaD
Meloxicam—PTGS2—Disease—TGFB1—chronic obstructive pulmonary disease	5.69e-06	0.000116	CbGpPWpGaD
Meloxicam—PTGS2—Disease—EGFR—chronic obstructive pulmonary disease	5.58e-06	0.000113	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.56e-06	0.000113	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.48e-06	0.000111	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.11e-06	0.000104	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	4.99e-06	0.000101	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.84e-06	9.84e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	4.78e-06	9.7e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—IL6—chronic obstructive pulmonary disease	4.29e-06	8.72e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.29e-06	6.69e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.15e-06	6.4e-05	CbGpPWpGaD
